Accelerating the world’s transition to a sustainable bio-economy
We lead the biotech revolution in agriculture
Hudson River Biotechnology intends to deliver on the promise that crop improvement through biotechnology can address the demands of a resilient, sustainable bio-economy. We solve plant production challenges across the value chain by delivering technologies to develop and grow crops of higher quality, more efficiently and sustainably.
We have developed solutions to enhance the functions of plants using CRISPR based plant breeding and deliver agrochemical inputs efficiently through targeted, smart delivery systems. By providing these technologies to our partners, we contribute to improving plant yields while reducing the inputs necessary, ultimately decreasing agriculture’s environmental impact.
Interested in learning more or have a general inquiry?
HRB INSIGHTS – R&D Optimization & Automation
Hudson River Biotechnology is an innovation-oriented company, with many brilliant scientists in the team. So how do we create an environment where our scientists can
HRB applies for patent for targeted delivery of crop care products and biologicals
March 15, Wageningen – To combat the current issues prevalent in field crop care, HRB and SE collaborated on PlentranceTM: a targeted, biodegradable particle for
Prof. Enrico Mastrobattista joins Hudson River Biotechnology’s Scientific Advisory Board and will advise on nanoparticle delivery
Professor Enrico Mastrobattista, full professor of Pharmaceutical Biotechnology & Delivery at the department of Pharmaceutical Sciences of Utrecht University, joins the Scientific Advisory Board of
Computomics and Hudson River Biotechnology Collaborate in Optimizing Plant Breeding with CRISPR
Computomics and Hudson River Biotechnology (HRB) will start offering AccelATrait™, a joint end-to-end solution using CRISPR-based gene editing for novel plant trait development. AccelATrait™ uses
Prof. Patricia Dankers joins Hudson River Biotechnology’s Scientific Advisory Board
Prof. Patricia Dankers, full professor of Biomedical Materials & Chemistry at the department of Biomedical Engineering and the Institute for Complex Molecular Systems of Eindhoven
Hudson River Biotechnology raises €5m Series A funding to accelerate growth of its plant gene editing business and expand into nanoparticles for use in field applications
Ferdinand Los, CSO at Hudson River Biotechnology: “We strongly believe in our ability to keep innovating and be at the forefront of technological developments. This